Literature DB >> 28216102

Complete genome sequence of Amycolatopsis orientalis CPCC200066, the producer of norvancomycin.

Xuan Lei1, Cong Zhang1, Zhibo Jiang1, Xingxing Li1, Yuanyuan Shi1, Ming Liu2, Yunying Xie1, Lifei Wang3, Bin Hong4.   

Abstract

Amycolatopsis orientalis CPCC200066 is an actinomycete exploited commercially in China for the production of norvancomycin, an important glycopeptide antibiotic structurally close to the well-known vancomycin. The availability of the complete genome sequence of CPCC200066 would greatly strengthen our understanding of the regulation pattern of norvancomycin biosynthesis and ultimately improve its production, as well as potentiate discoveries of novel bioactive compounds. Here we report the complete genome sequence of A. orientalis CPCC200066, a circular chromosome consisting of 9,490,992bp. Forty putative secondary metabolite biosynthetic gene clusters, including norvancomycin, were predicted, covering 20.3% of the whole genome. To facilitate genetic manipulation of this strain, an efficient transformation system was established by constructing a novel integrative vector pIMBT1, which could be transferred into CPCC200066 by electroporation with high efficiency. ΦBT1 attB sites were also identified in other known Amycolatopsis genomes, indicating pIMBT1's prospect to be a novel vector for genus Amycolatopsis.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amycolatopsis orientalis CPCC200066; Complete genome sequence; Integrative vector pIMBT1; Norvancomycin

Mesh:

Substances:

Year:  2017        PMID: 28216102     DOI: 10.1016/j.jbiotec.2017.02.013

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  1 in total

1.  Integrating vectors for genetic studies in the rare Actinomycete Amycolatopsis marina.

Authors:  Hong Gao; Buvani Murugesan; Janina Hoßbach; Stephanie K Evans; W Marshall Stark; Margaret C M Smith
Journal:  BMC Biotechnol       Date:  2019-06-04       Impact factor: 2.563

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.